Fundz
Free weekly newsletter

Get the free weekly executive digest

The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New leadership moves, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Leadership Trends

See who's moving and how much in your market

No credit card required Weekly executive digest

Asymchem Welcomes Dr. Cheng Yi Chen As Chief Technical Officer (CTO) for Small Molecule Market

PRIVATEJun 26, 2024•almost 2 years ago

Position

Chief Technical Officer

Company

Asymchem

Cheng Yi Chen
TianjinManufacturingBiotechnologyScience And EngineeringPharmaceutical

Description

Dr. Cheng Yi Chen officially joined Asymchem as the Chief Technical Officer (CTO) for the small molecule market on June 18, 2024. In his new role, he will provide technical support for the group's sales of small chemical molecules in the European and American markets, actively participate in technical communications for key clinical projects, and offer expertise in technical matters related to projects with European and American clients.

Company Information

Company

Asymchem

Location

Tianjin, Tianjin, China

About

Asymchem is a leading global manufacturer of pharmaceutical ingredients and a trusted partner to pharmaceutical and biotechnology companies worldwide. With a robust track record and a deep commitment to quality and innovation, Asymchem offers a comprehensive range of services, including custom synthesis, process development, and manufacturing of small molecules, peptides, oligonucleotides, and biologics.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Asymchem's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.